438 related articles for article (PubMed ID: 25022961)
1. MIF inhibits monocytic movement through a non-canonical receptor and disruption of temporal Rho GTPase activities in U-937 cells.
DiCosmo-Ponticello CJ; Hoover D; Coffman FD; Cohen S; Cohen MC
Cytokine; 2014 Sep; 69(1):47-55. PubMed ID: 25022961
[TBL] [Abstract][Full Text] [Related]
2. MIF, CD74 and other partners in kidney disease: tales of a promiscuous couple.
Sanchez-Niño MD; Sanz AB; Ruiz-Andres O; Poveda J; Izquierdo MC; Selgas R; Egido J; Ortiz A
Cytokine Growth Factor Rev; 2013 Feb; 24(1):23-40. PubMed ID: 22959722
[TBL] [Abstract][Full Text] [Related]
3. Role for CD74 and CXCR4 in clathrin-dependent endocytosis of the cytokine MIF.
Schwartz V; Krüttgen A; Weis J; Weber C; Ostendorf T; Lue H; Bernhagen J
Eur J Cell Biol; 2012; 91(6-7):435-49. PubMed ID: 22014447
[TBL] [Abstract][Full Text] [Related]
4. LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF.
Klasen C; Ziehm T; Huber M; Asare Y; Kapurniotu A; Shachar I; Bernhagen J; El Bounkari O
Cell Signal; 2018 Jun; 46():32-42. PubMed ID: 29476963
[TBL] [Abstract][Full Text] [Related]
5. MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling.
Klasen C; Ohl K; Sternkopf M; Shachar I; Schmitz C; Heussen N; Hobeika E; Levit-Zerdoun E; Tenbrock K; Reth M; Bernhagen J; El Bounkari O
J Immunol; 2014 Jun; 192(11):5273-84. PubMed ID: 24760155
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase.
Fan H; Hall P; Santos LL; Gregory JL; Fingerle-Rowson G; Bucala R; Morand EF; Hickey MJ
J Immunol; 2011 Apr; 186(8):4915-24. PubMed ID: 21411731
[TBL] [Abstract][Full Text] [Related]
7. Expression and function of macrophage migration inhibitory factor in the pathogenesis of UV-induced cutaneous nonmelanoma skin cancer.
Heise R; Vetter-Kauczok CS; Skazik C; Czaja K; Marquardt Y; Lue H; Merk HF; Bernhagen J; Baron JM
Photochem Photobiol; 2012; 88(5):1157-64. PubMed ID: 22324658
[TBL] [Abstract][Full Text] [Related]
8. Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells.
Ohta S; Misawa A; Fukaya R; Inoue S; Kanemura Y; Okano H; Kawakami Y; Toda M
J Cell Sci; 2012 Jul; 125(Pt 13):3210-20. PubMed ID: 22454509
[TBL] [Abstract][Full Text] [Related]
9. Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74.
Lue H; Dewor M; Leng L; Bucala R; Bernhagen J
Cell Signal; 2011 Jan; 23(1):135-44. PubMed ID: 20807568
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors.
Lourenco S; Teixeira VH; Kalber T; Jose RJ; Floto RA; Janes SM
J Immunol; 2015 Apr; 194(7):3463-74. PubMed ID: 25712213
[TBL] [Abstract][Full Text] [Related]
11. Compartmentalized protective and detrimental effects of endogenous macrophage migration-inhibitory factor mediated by CXCR2 in a mouse model of myocardial ischemia/reperfusion.
Liehn EA; Kanzler I; Konschalla S; Kroh A; Simsekyilmaz S; Sönmez TT; Bucala R; Bernhagen J; Weber C
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2180-6. PubMed ID: 23868943
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex.
Le Hiress M; Tu L; Ricard N; Phan C; Thuillet R; Fadel E; Dorfmüller P; Montani D; de Man F; Humbert M; Huertas A; Guignabert C
Am J Respir Crit Care Med; 2015 Oct; 192(8):983-97. PubMed ID: 26203495
[TBL] [Abstract][Full Text] [Related]
13. Both host and parasite MIF molecules bind to chicken macrophages via CD74 surface receptor.
Kim S; Cox CM; Jenkins MC; Fetterer RH; Miska KB; Dalloul RA
Dev Comp Immunol; 2014 Dec; 47(2):319-26. PubMed ID: 25086294
[TBL] [Abstract][Full Text] [Related]
14. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
[TBL] [Abstract][Full Text] [Related]
15. Serum Levels of Migration Inhibitory Factor (MIF) and
Martinez-Guzman MA; Alvarado-Navarro A; Delgado-Rizo V; Garcia-Orozco A; Mayorga-Rodríguez JA; Pereira-Suarez AL; Fafutis-Morris M
Front Immunol; 2018; 9():246. PubMed ID: 29487601
[TBL] [Abstract][Full Text] [Related]
16. A functional heteromeric MIF receptor formed by CD74 and CXCR4.
Schwartz V; Lue H; Kraemer S; Korbiel J; Krohn R; Ohl K; Bucala R; Weber C; Bernhagen J
FEBS Lett; 2009 Sep; 583(17):2749-57. PubMed ID: 19665027
[TBL] [Abstract][Full Text] [Related]
17. Macrophage Migration Inhibitory Factor (MIF)-Based Therapeutic Concepts in Atherosclerosis and Inflammation.
Sinitski D; Kontos C; Krammer C; Asare Y; Kapurniotu A; Bernhagen J
Thromb Haemost; 2019 Apr; 119(4):553-566. PubMed ID: 30716779
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD74 Reroutes MIF/CXCR4/AKT-Mediated Survival of Cardiac Myofibroblasts to Necroptosis.
Soppert J; Kraemer S; Beckers C; Averdunk L; Möllmann J; Denecke B; Goetzenich A; Marx G; Bernhagen J; Stoppe C
J Am Heart Assoc; 2018 Sep; 7(17):e009384. PubMed ID: 30371153
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between macrophage migration inhibitory factor and eotaxin in allergic eosinophil activation forms leukotriene C₄-synthesizing lipid bodies.
Vieira-de-Abreu A; Calheiros AS; Mesquita-Santos FP; Magalhães ES; Mourão-Sá D; Castro-Faria-Neto HC; Bozza MT; Bandeira-Melo C; Bozza PT
Am J Respir Cell Mol Biol; 2011 Apr; 44(4):509-16. PubMed ID: 20539011
[TBL] [Abstract][Full Text] [Related]
20. The macrophage migration inhibitory factor pathway in human B cells is tightly controlled and dysregulated in multiple sclerosis.
Rijvers L; Melief MJ; van der Vuurst de Vries RM; Stéphant M; van Langelaar J; Wierenga-Wolf AF; Hogervorst JM; Geurts-Moespot AJ; Sweep FCGJ; Hintzen RQ; van Luijn MM
Eur J Immunol; 2018 Nov; 48(11):1861-1871. PubMed ID: 30160778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
